Discovery of New Eunicellins from an Indonesian Octocoral Cladiella sp. by Chen, Yung-Husan et al.
Mar. Drugs 2011, 9, 934-943; doi:10.3390/md9060934 
 
Marine Drugs  
ISSN 1660-3397 
www.mdpi.com/journal/marinedrugs 
Article 
Discovery of New Eunicellins from an Indonesian Octocoral 
Cladiella sp. 
Yung-Husan Chen 
1, Chia-Ying Tai 
1,2, Yin-Di Su 
1,3, Yu-Chia Chang 
1,4, Mei-Chin Lu 
1,2,  
Ching-Feng Weng 
5, Jui-Hsin Su 
1,2,6, Tsong-Long Hwang 
7, Yang-Chang Wu 
8,9,* and  
Ping-Jyun Sung 
1,2,3,5,6,* 
1  National Museum of Marine Biology and Aquarium, Pingtung 944, Taiwan;  
E-Mails: tony_chen72001@yahoo.com.tw (Y.-H.C.); j19851214@hotmail.com (C.-Y.T.); 
gobetter04@yahoo.com.tw (Y.-D.S.); jay0404@gmail.com (Y.-C.C.);  
jinx6609@nmmba.gov.tw (M.-C.L.); x2219@nmmba.gov.tw (J.-H.S.)  
2  Graduate Institute of Marine Biotechnology, National Dong Hwa University, Pingtung 944, Taiwan 
3  Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung 
804, Taiwan 
4  Doctoral Degree Program in Marine Biotechnology, National Sun Yat-sen University and 
Academia Sinica, Kaohsiung 804, Taiwan 
5  Department of Life Science and Institute of Biotechnology, National Dong Hwa University, 
Hualien 974, Taiwan; E-Mail: cfweng@mail.ndhu.edu.tw (C.-F.W.) 
6  Division of Marine Biotechnology, Asia-Pacific Ocean Research Center, National Sun Yat-sen 
University, Kaohsiung 804, Taiwan 
7  Graduate Institute of Natural Products, Chang Gung University, Taoyuan 333, Taiwan;  
E-Mail: htl@mail.cgu.edu.tw (T.-L.H.) 
8  Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, 
Taichung 404, Taiwan 
9  Natural Medicinal Products Research Center, China Medical University Hospital, Taichung 404, 
Taiwan 
*  Authors to whom correspondence should be addressed;  
E-Mails: yachwu@mail.cmu.edu.tw (Y.-C.W.); pjsung@nmmba.gov.tw (P.-J.S.);  
Tel.: +886-8-8825037 (P.-J.S.); Fax: +886-8-8825087 (P.-J.S.). 
Received: 14 April 2011; in revised form: 18 May 2011 / Accepted: 25 May 2011 /  
Published: 26 May 2011 
 
Abstract:  Two  new  11-hydroxyeunicellin  diterpenoids,  cladieunicellin  F  (1)  and  
(–)-solenopodin  C  (2),  were  isolated  from  an  Indonesian  octocoral  Cladiella  sp.  The 
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structures  of  eunicellins  1  and  2  were  established  by  spectroscopic  methods,  and 
eunicellin 2 was found to be an enantiomer of the known eunicellin solenopodin C (3). 
Eunicellin 2 displayed inhibitory effects on the generation of superoxide anion and the 
release  of  elastase  by  human  neutrophils.  The  previously  reported  structures  of  two 
eunicellin-based compounds, cladielloides A and B, are corrected in this study. 
Keywords: cladieunicellin; eunicellin; octocoral; Cladiella; superoxide anion; elastase 
 
1. Introduction 
As part of our ongoing investigation into the isolation of new natural substances from octocorals 
collected  in  the  tropical  West  Pacific  Ocean,  a  series  of  interesting  diterpenoids,  including  
cembrane-type [1], eunicellin-type (2,11-cyclized cembranoid) [2–4], and briarane-type (3,8-cyclized 
cembranoid)  [5–7]  diterpenoids,  were  isolated  from  various  octocorals  belonging  to  the  genera 
Briareum, Cladiella, Ellisella, and Junceella. The chemical constituents of an Indonesian octocoral 
identified  as  Cladiella  sp.  were  examined,  and  nine  new  eunicellin-based  diterpenoids,  including 
cladieunicellins A–E [2] and cladielloides A–D [3,4], were isolated. Further study of this coral yielded 
two new eunicellins, cladieunicellin F (1) and (–)-solenopodin C (2). In this paper, we report the 
isolation, structure determination, and bioactivity of new eunicellins 1 and 2 (Figure 1). 
Figure 1. The structures of cladieunicellin F (1), (−)-solenopodin C (2), and solenopodin C (3). 
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2. Results and Discussion 
Cladieunicellin F (1) was isolated as a colorless oil and the molecular formula for this compound 
was  determined  using  HRESIMS  to  be  C20H34O3  (four  degrees  of  unsaturation)  (m/z  345.2404  
[M + Na]
+, calculated for 345.2406). Comparison of the 
13C NMR and DEPT data with the molecular 
formula indicated that there must be two exchangeable protons, which required the presence of two 
hydroxyl groups. This deduction was supported by a broad absorption in the IR spectrum at 3414 cm
−1. 
The 
13C NMR data for 1 confirmed the presence of twenty carbon signals (Table 1), which were 
characterized  by  DEPT  as  four  methyls,  an  sp
2  methylene,  six  sp
3  methylenes,  six  sp
3  methines 
(including two oxymethines), two sp
3 oxygenated quaternary carbons, and an sp
2 quaternary carbon. 
Based  on  the 
1H  and 
13C  NMR  spectra  (Table  1),  1  was  determined  to  possess  an  exocyclic  Mar. Drugs 2011, 9                       
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carbon-carbon double bond (H 5.06, 2H, br s, H2-16; C 150.6, s, C-7; 111.8, t, C-16). The presence of 
a  trisubstituted  epoxide  containing  a  methyl  substituent  was  established  from  the  signals  of  an 
oxygenated quaternary carbon (C 62.9, s, C-3) and an oxymethine (H 2.81, 1H, d, J = 9.6 Hz; C 64.8, 
d, CH-2) and confirmed by the proton signal of a methyl singlet at H 1.36 (3H, s, H3-15). In the  
1H NMR spectrum of 1, two doublets at H 0.88 and 0.81 (each 3H, d, J = 6.4 Hz, H3-19 and H3-20) 
were  indicative of  the  two methyls  of an isopropyl  group. A tertiary  methyl  group  bonded to  an 
oxygenated carbon was  evident from the singlet signal at  H 1.24 (3H, s, H3-17). Thus, from the 
reported data, the proposed skeleton of 1 was suggested to be an eunicellin-based diterpenoid with 
three rings.  
Table 1. 
1H and 
13C NMR data, 
1H–
1H COSY, and HMBC correlations for diterpenoid 1. 
C/H 
1H
a  
13C
b  
1H–
1H COSY  HMBC (H→C) 
1  2.12 m  36.0  (d)
d  H-2, H-10, H-14  C-2, C-3, C-9, C-10, C-11, C-14, C-18 
2  2.81 d (9.6)
c  64.8  (d)  H-1  C-1, C-3, C-10, C-15 
3    62.9  (s)     
4a 
b 
1.27 m 
1.81 m 
27.3  (t)  H-4b, H2-5 
H-4a, H2-5 
C-3, C-5, C-15 
C-2, C-3, C-5, C-6, C-15 
5 2.01 m  30.3  (t)  H2-4, H-6  C-3, C-4, C-6, C-7 
6  4.20 dd (10.4, 4.0)  68.4  (d)  H2-5  C-16 
7    150.6  (s)     
8a 
b 
2.16 m 
2.61 m 
37.5  (t)  H-8b, H2-9 
H-8a, H2-9, H2-16 
n.o.
e 
C-7, C-9, C-10, C-16 
9a 
b 
1.44 m 
1.96 m 
22.9  (t)  H2-8, H-9b, H-10 
H2-8, H-9a, H-10 
n.o. 
C-1, C-7, C-8 
10  1.68 dd (10.8, 6.0)  46.1  (d)  H-1, H2-9  C-1, C-2, C-8, C-9, C-11, C-12, C-17 
11    72.9  (s)     
12  1.59 m  37.2  (t)  H2-13  C-10, C-11, C-13, C-14, C-17 
13a 
b 
1.55 m 
1.71 m 
21.8  (t)  H2-12, H-13b, H-14 
H2-12, H-13a, H-14 
C-11, C-12, C-14 
C-11, C-12, C-14 
14  1.32 m  41.5  (d)  H-1, H2-13, H-18  C-13 
15  1.36 s  21.8  (q)    C-2, C-3, C-4 
16  5.06 br s  111.8  (t)  H-8b  C-6, C-7, C-8 
17  1.24 s  24.4  (q)    C-10, C-11, C-12 
18  1.81 m  26.5  (d)  H-14, H3-19, H3-20  C-14, C-19, C-20 
19  0.88 d (6.4)  20.6  (q)  H-18  C-14, C-18, C-20 
20  0.81 d (6.4)  21.7  (q)  H-18  C-14, C-18, C-19 
a Spectra were measured at 400 MHz in CDCl3. 
b Spectra were measured at 100 MHz in CDCl3. 
c J values (in 
hertz)  are  in  parentheses. 
d  Attached  protons  were  deduced  by  DEPT  and  HMQC  experiments.  
e n.o. = not observed.  
From the 
1H–
1H COSY spectrum of 1 (Table 1), it was possible to differentiate among the separate 
spin  systems  of  H-1/H-2,  H2-4/H2-5/H-6,  H2-8/H2-9/H-10/H-1,  H2-12/H2-13/H-14/H-1,  and  
H-14/H-18/H3-19  (H3-20),  which  was  accomplished  with  the  assistance  of  an  HMBC  experiment 
(Table 1). The key HMBC correlations between the protons and quaternary carbons of 1, including  
H-1,  H-2,  H2-4,  H2-5,  H3-15/C-3;  H2-5,  H-8b,  H-9b,  H2-16/C-7;  and  H-1,  H-10,  H2-12,  H2-13,  Mar. Drugs 2011, 9                       
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H3-17/C-11, permitted the elucidation of the carbon skeleton. An exocyclic carbon-carbon double bond 
at C-7 was confirmed by the HMBC correlations between H2-16/C-6, -7, -8; H-6/C-16; and H-8b/C-16 
and further supported by the allylic coupling between H-8b/H2-16. The presence of the C-2/3 epoxide 
group was confirmed by the HMBC correlations between H-1/C-2, -3; H-2/C-1, -3, -10, -15; H2-4/C-2, 
-3; and H3-15/C-2, -3, -4. Thus, the remaining hydroxyl groups should be positioned at C-6 and C-11, 
as  indicated  by  the  key 
1H–
1H  COSY  correlations  and  characteristic  NMR  signals,  although  the 
hydroxyl protons for OH-6 and OH-11 were not observed in the 
1H NMR spectrum of 1.  
The  relative  configuration  of  1  was  elucidated  from  the  interactions  observed  in  a  NOESY 
experiment  (Figure  2):  H-1  correlated  with  H-10  and  H3-20,  indicating  that  H-1,  H-10,  and  the 
isopropyl group are situated on the same face and assigned as  protons. H-2 exhibited interactions 
with H-14 and Me-17, and no correlation was found between H-1/H-2, H-10/Me-17, and H-2/Me-15, 
indicating  that  H-2,  H-14,  and  Me-17  should  be  -oriented  and  Me-15  should  be  -oriented. 
Furthermore, H-6 correlated with two protons of the C-9 methylene  and Me-15. Consideration of 
molecular models found that H-6 was reasonably close to H2-9 and Me-15 when H-6 was -oriented in 
1. Based on the above findings, the structure of 1, including its relative configuration, was established, 
and the chiral centers for 1 were assigned as 1R*, 2S*, 3S*, 6R*, 10R*, 11R*, and 14R*. To the best of 
our knowledge, cladieunicellin F (1) is the first eunicellin derivative possessing a C-2/3 epoxy group.  
Figure 2. Selective NOESY correlations for 1. 
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Eunicellin  2  was  isolated  as  a  colorless  oil,  and  the  molecular  formula  of  this  compound  was 
determined using HRESIMS to be C20H34O2 (m/z 329.2455 [M + Na]
+, calculated for 329.2456). Thus, 
four degrees of unsaturation were determined for 2. Detailed analysis of the NMR data showed that the 
data for 2 were similar to those of a known eunicellin analogue, solenopodin C (3) (Figure 1), which 
was isolated from the gorgonian Solenopodium stechei [8]. However, the optical rotation value of 2 
([]
22
D −51 (c 0.17, CHCl3)) was substantially different from that of 3 ([]
22
D +105.6 (c 0.36)), indicating 
that eunicellin 2 is an enantiomer of 3 and should be designated (–)-solenopodin C. The 
1H and 
13C 
NMR data for 2 (Table 2) were assigned using 2D NMR data analysis and comparison to the NMR 
data of 3. The proton chemical shifts for C-8, C-9, C-12, and C-13 methylene protons and the carbon 
chemical shifts for C-1, C-4, C-12, and C-14 of compound 3 should be revised (Table 2).  Mar. Drugs 2011, 9                       
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Table 2. 
1H and 
13C NMR data for diterpenoids 2 and 3. 
  2    3 
C/H 
1H
a  
13C
b
  1H
e  
13C
e
1  2.73 ddd (7.6, 6.0, 6.0)
c  36.6  (d)
d    2.73 ddd (7.5, 6, 6)  44.8  (d) 
2  5.35 d (7.6)  130.4  (d)    5.34 br d (7.5)  130.4  (d) 
3    134.3  (s)      134.3  (s) 
4a 
b 
2.47 ddd (13.2, 13.2, 2.8) 
1.95 m 
28.0  (t)    2.47 ddd (13.4, 13, 2.2) 
1.9 m 
35.2  (t) 
5a 
b 
2.13 m 
1.37 m 
25.3  (t)    2.1 m 
1.3 m 
25.3  (t) 
6  3.10 dd (10.8, 3.6)  65.9  (d)    3.10 dd (11.2, 3.5)  65.9  (d) 
7    61.2  (s)      61.1  (s) 
8a 
b 
2.14 m 
0.93 m 
38.6  (t)    2.3 m  38.6  (t) 
9a 
b 
1.58 m 
0.90 m 
22.5  (t)    1.2–1.7 m  22.2  (t) 
10  1.95 m  47.3  (d)    1.95 ddd (6, 6, 6)  47.3  (d) 
11    73.2  (s)      73.2  (s) 
12a 
b 
1.52 m 
1.49 m 
35.2  (t)      28.1  (t) 
13a 
b 
1.56 m 
1.45 m 
20.0  (t)      20.0  (t) 
14  1.02 m  44.7  (d)    1.0 m  36.6  (d) 
15  1.71 s  24.9  (q)    1.71 s  24.9  (q) 
16  1.18 s  18.2  (q)    1.22 s  18.2  (q) 
17  1.22 s  26.7  (q)    1.18 s  26.8  (q) 
18  1.95 m  26.6  (d)    1.90 m  26.6  (d) 
19  0.97 d (6.8)  22.0  (q)    0.78 d (7)  22.0  (q) 
20  0.78 d (6.8)  17.6  (q)    0.98 d (7)  17.7  (q) 
a Spectra were measured at 400 MHz in CDCl3. 
b Spectra were measured at 100 MHz in CDCl3. 
c J values (in 
hertz) are in parentheses. 
d Attached protons were deduced by DEPT and HMQC experiments. 
e Data were 
reported by Bloor et al. [8]. These data were measured at 300 MHz for 
1H and 75 MHz for 
13C in CDCl3. 
In  a  previous  study,  we  reported  the  isolation  and  structure  determination  of  two  eunicellins, 
cladielloides A (4) and B (5) (Figure 3) [3]. However, based on detailed spectral data analysis, we 
found that the structures for these two compounds should be revised. 1D and 2D NMR spectral data 
analysis, particularly 
1H–
1H COSY and HMBC experiments, of cladielloide A (Table 3), showed that 
the  main  carbon  skeleton  of  cladielloide  A  was  established  correctly.  However,  in  the  HMBC 
experiment  for  cladielloide  A,  key  correlations  between  H-4  (H  5.14)  and  an  ester  carbonyl  at  
C 171.4 (s, C-1') and between H-2' (H 4.86) and two ester carbonyls at C 171.4 (s, C-1') and 171.1 
(s, acetate  carbonyl)  were  detected,  and  these  findings  indicated  that  the  2'-acetoxybutyrate  group 
should be positioned at C-4. Thus, the remaining hydroxyl groups are attached at C-3 and C-6 in 
cladielloide A, respectively. Furthermore, in the NOESY spectrum of cladielloide A, H-6 (H 4.21) 
correlated with H2-5 (H 2.97 and 1.75) and H2-8 (H 2.35), but no correlation was found between H-6 
and H3-15. Consideration of molecular models found that H-6 was reasonably close to H2-5 and H2-8 Mar. Drugs 2011, 9                       
 
 
939 
when it was -oriented. Based on the above findings, the structure, including the relative configuration, 
of  cladielloide  A  should  be  revised  as  presented  in  eunicellin  6.  Cladielloide  B  was  found  by 
HRESIMS to be an isomer of cladielloide A [3]. These two compounds were found to possess the 
same  planar  structure  by  NMR  data  analysis  (Tables  3  and  4).  In  the  NOESY  experiment  of 
cladielloide B, H-6 (H 4.66) exhibited correlations with H3-15 (H 1.33); a proton of C-5 methylene 
(H 2.48); and a proton of C-8 methylene (H 2.65), indicating that the 6-hydroxyl group in cladielloide 
B should be -oriented as presented as eunicellin 7. Based on the above findings, the structures of 
cladielloides A and B should be revised as structures 6 and 7, respectively. The authors apologize for 
any inconvenience caused by these errors.  
Figure 3. The previously reported structures of cladielloides A (4) and B (5) and their 
revised structures 6 and 7, respectively. 
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4: R1 = OAc, R2 = OH; 5: R1 = OH, R2 = OAc  6: R = -OH (revised); 7: R = -OH (revised) 
Table 3. 
1H and 
13C NMR data, 
1H–
1H COSY, and HMBC correlations for cladielloide A (6). 
C/H 
1H
a 
13C
b   
1H–
1H COSY  HMBC (H→C) 
1  2.74 ddd (8.0, 8.0, 4.0)
c  39.7  (d)
d  H-2, H-10, H-14  C-2, C-3, C-10, C-11, C-14 
2  3.86 d (8.0)  87.1  (d)  H-1  C-3, C-4, C-14, C-15 
3    74.1  (s)     
4  5.14 dd (4.4, 4.4)  74.6  (d)  H2-5  C-3, C-6, C-15, C-1' 
5 

2.97 ddd (16.0, 4.4, 2.8) 
1.75 ddd (16.0, 5.6, 3.6) 
37.2  (t)  H-4, H-5, H-6 
H-4, H-5, H-6 
C-3 
C-3, C-4, C-7 
6  4.21 br s  72.6  (d)  H2-5, OH-6  n.o.
e 
7    147.6  (s)     
8  2.35 br d (2.4)  40.0  (t)  H-9  C-6, C-7, C-9, C-10, C-16 
9  4.16 ddd (3.6, 3.2, 3.2)  81.3  (d)  H2-8, H-10  n.o.  
10  2.63 br s  44.6  (d)  H-1, H-9  C-11 
11    132.1  (s)     
12  5.43 m  122.2  (d)  H2-13, H3-17  n.o. 
13
 
2.10 m 
1.98 m 
22.8  (t)  H-12, H-13, H-14 
H-12, H-13, H-14 
n.o. 
n.o. 
14  1.58 m  39.0  (d)  H-1, H2-13, H-18  n.o.  
15  1.37 s  22.4  (q)    C-2, C-3, C-4 
16a 
b 
5.21 s 
5.58 s  
115.2  (t)  H-16b 
H-16a 
C-6, C-8 
C-6, C-7, C-8 
17  1.68 d (0.8)  22.0  (q)  H-12   Mar. Drugs 2011, 9                       
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Table 3. Cont. 
18  1.15 m  28.8  (d)  H-14, H3-19, H3-20   
19  0.92 d (6.4)  21.3  (q)  H-18  C-14, C-18, C-20 
20  0.83 d (6.4)  20.5  (q)  H-18  C-14, C-18, C-19 
OH-6  2.84 d (7.2)      H-6  n.o. 
1'    171.4  (s)     
2'  4.86 dd (6.8, 6.0)  74.4  (d)  H2-3'  C-1', C-3', C-4', acetate carbonyl 
3'  1.91 m   24.3  (t)  H-2', H3-4'  C-1', C-2', C-4' 
4'  1.03 t (7.2)  9.3  (q)  H2-3'  C-2', C-3' 
2'-OAc   
2.14 s 
171.1 
20.6 
(s) 
(q) 
   
Acetate carbonyl 
a Spectra were measured at 400 MHz in CDCl3. 
b Spectra were measured at 100 MHz in CDCl3. 
c J values (in 
hertz)  are  in  parentheses. 
d  Attached  protons  were  deduced  by  DEPT  and  HMQC  experiments.  
e n.o. = not observed. 
Table 4. 
1H and 
13C NMR data, 
1H–
1H COSY, and HMBC correlations for cladielloide B (7). 
C/H 
1H
a  
13C
b  
1H–
1H COSY  HMBC (H→C) 
1  2.51 m  40.6  (d)
d  H-2, H-10, H-14  C-10 
2  3.90 d (3.6)
c  88.1  (d)  H-1  C-1, C-3, C-4, C-10 
3    74.8  (s)     
4  5.21 dd (8.0, 4.0)  73.8  (d)  H2-5  C-5, C-6, C-1' 
5

2.48 m 
1.97 m 
34.2  (t)  H-4, H-5, H-6 
H-4, H-5, H-6 
C-6, C-7 
n.o.
e 
6  4.66 dd (8.8, 3.2)  83.8  (d)  H2-5  C-4, C-7, C-16 
7    144.2  (s)     
8
 
2.65 dd (14.0, 4.8) 
2.46 dd (14.0, 2.0) 
41.4  (t)  H-8, H-9, H-16a 
H-8, H-9 
C-7, C-9, C-10, C-16 
C-6, C-7, C-16 
9  4.06 br s  82.4  (d)  H2-8, H-10  n.o. 
10  2.58 br s  44.7  (d)  H-1, H-9  C-8, C-9, C-11 
11    131.1  (s)     
12  5.49 m  123.1  (d)  H2-13, H3-17  n.o. 
13

2.01 m 
1.80 m 
22.9  (t)  H-12, H-13, H-14 
H-12, H-13, H-14 
n.o. 
n.o. 
14  1.39 m  39.8  (d)  H-1, H2-13, H-18  C-1, C-2 
15  1.33 s  22.8  (q)    C-2, C-3, C-4 
16a 
b 
5.26 s 
5.47 s 
117.7  (t)  H-8, H-16b 
H-16a 
C-6, C-8 
C-6, C-7, C-8 
17  1.69 d (1.2)  22.8  (q)  H-12  C-10, C-11, C-12 
18  1.80 m  27.8  (d)  H-14, H3-19, H3-20  C-14, C-19, C-20 
19  0.94 d (6.8)  21.7  (q)  H-18  C-14, C-18, C-20 
20  0.77 d (6.8)  17.5  (q)  H-18  C-14, C-18, C-19 
1'    170.2  (s)     
2'  4.87 dd (6.8, 6.0)  74.3  (d)  H2-3'  C-1',  C-3',  C-4',  acetate 
carbonyl 
3'  1.91 m  24.5  (t)  H-2', H3-4'  C-1', C-2', C-4' 
4'  1.02 t (7.2)  9.3  (q)  H2-3'  C-2', C-3' Mar. Drugs 2011, 9                       
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Table 4. Cont. 
2'-OAc   
2.14 s 
171.6 
20.6 
(s) 
(q) 
   
Acetate carbonyl 
a Spectra were measured at 400 MHz in CDCl3. 
b Spectra were measured at 100 MHz in CDCl3. 
c J values (in 
hertz)  are  in  parentheses. 
d  Attached  protons  were  deduced  by  DEPT  and  HMQC  experiments.  
e n.o. = not observed.  
The in vitro anti-inflammatory effects of eunicellins 1 and 2 were tested. Eunicellin 2 displayed 
significant  inhibitory  effects on  the generation  of  superoxide anion  and the release of  elastase  by 
human neutrophils at a concentration of 10g/mL (Table 5). 
Table 5. Inhibitory effects of eunicellins 1 and 2 on the generation of superoxide anion and 
the release of elastase by human neutrophils in response to FMLP/CB. 
  Superoxide anion    Elastase release 
Compounds  Inh%    Inh% 
1  6.46 ±  1.28 **    12.91 ±  3.56 * 
2  45.82 ±  2.49 ***    40.45 ±  5.80 ** 
Percentage  of  inhibition  (Inh%)  at  10  g/mL  concentration  of  1  and  2.  Results  are  presented  as  the  
mean + S.E.M. (n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, as compared with the control value [9]. 
3. Experimental Section 
3.1. General Experimental Procedures 
Optical rotation values were measured with a JASCO P-1010 digital polarimeter. Infrared spectra 
were obtained on a VARIAN DIGLAB FTS 1000 FT-IR spectrophotometer. The NMR spectra were 
recorded on a VARIAN MERCURY PLUS 400 FT-NMR at 400 MHz and 100 MHz for 
1H and 
13C 
spectra, respectively, in CDCl3 at 25 °C . Proton chemical shifts were referenced to the residual CHCl3 
signal (H 7.26 ppm). 
13C NMR spectra were referenced to the center peak of CDCl3 at C 77.1 ppm. 
ESIMS  and  HRESIMS  data  were  recorded  on  a  BRUKER  APEX  II  mass  spectrometer.  Column 
chromatography was performed on silica gel (230–400 mesh, Merck, Darmstadt, Germany). TLC was 
carried out on precoated Kieselgel 60 F254 (0.25 mm, Merck), and spots were visualized by spraying 
with 10% H2SO4 solution followed by heating. HPLC was performed using a system comprised of a 
HITACHI L-2130 pump, a HITACHI photodiode array detector L-2455, and a RHEODYNE 7725 
injection port. A reverse phase column (Polaris 5 C18-A 250 ×  10.0 mm, Varian, silica gel 60, 5 m) 
was used for HPLC. 
3.2. Animal Material  
The octocoral Cladiella sp. was collected and imported legitimately by the National Museum of 
Marine Biology and Aquarium (NMMBA), Taiwan from Indonesia in 2004. The material was stored 
in a freezer until extraction procedures were applied. A voucher specimen (NMMBA-IND-SC-001) 
was deposited in the NMMBA, Taiwan. This organism was identified by comparison with previous 
descriptions [10,11]. Mar. Drugs 2011, 9                       
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3.3. Extraction and Isolation 
Sliced bodies of Cladiella sp. (wet weight, 924 g) were extracted with a mixture of MeOH and 
CH2Cl2 (1:1), and the residue collected after solvent evaporation was partitioned between EtOAc and 
H2O. The EtOAc layer was subjected to silica gel column chromatography and eluted using a mixture 
of n-hexane and EtOAc (stepwise from 100:1 to 0:100 n-hexane:EtOAc) to obtain 19 fractions, labeled 
A–S. Fractions F and I were separated by reverse phase HPLC using a mixture of MeOH and water to 
afford eunicellins 2 (3.3 mg, 1/1) and 1 (1.5 mg, 1/1), respectively.  
Cladieunicellin F (1): colorless oil; []
23
D −194 (c 0.07, CHCl3); IR (neat) max 3414 cm
−1; 
1H NMR 
(CDCl3, 400 MHz) and 
13C NMR (CDCl3, 100 MHz) data, see Table 1; ESIMS m/z 345 [M + Na]
+; 
HRESIMS m/z 345.2404 (Calcd for 345.2406). 
(–)-Solenopodin C (2): colorless oil; []
22
D −51 (c 0.17, CHCl3); IR (neat) max 3427 cm
−1; 
1H NMR 
(CDCl3, 400 MHz) and 
13C NMR (CDCl3, 100 MHz) data, see Table 2; ESIMS m/z 329 [M + Na]
+; 
HRESIMS m/z 329.2455 (Calcd for 329.2456). 
3.4. Superoxide Anion Generation and Elastase Release by Human Neutrophils 
Human  neutrophils  were  obtained  using  dextran  sedimentation  and  Ficoll  centrifugation. 
Measurements  of  superoxide  anion  generation  and  elastase  release  were  carried  out  according  to 
previously  described  procedures  [12,13].  Briefly,  superoxide  anion  production  was  assayed  by 
monitoring  the  superoxide  dismutase-inhibitable  reduction  of  ferricytochrome  c.  Elastase  release 
experiments were performed using MeO-Suc-Ala-Ala-Pro-Valp-nitroanilide as the elastase substrate.  
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